[{"Assets_0_Q2_USD":160543734.0,"CommonStockSharesOutstanding_0_Q2_shares":38310884.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-9919781.0,"NetIncomeLoss_1_Q2_USD":-7427440.0,"NetIncomeLoss_2_Q2_USD":-13065858.0,"StockholdersEquity_0_Q2_USD":150503295.0,"Ticker":"AXGN","CIK":"805928","name":"AXOGEN, INC.","OfficialName":"Axogen Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"313567338.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20180801"}]